Manipulating the immune system to treat cancer has generated phenomenal responses in some patients, including complete cures, ...

Research into immunotherapy against cancer typically focuses on better recognition of cancer cells by the body's own immune ...

City of Hope® Research Spotlight offers a glimpse at groundbreaking scientific and clinical discoveries advancing lifesaving cures for patients with cancer, diabetes and other chronic, ...

Research into immunotherapy against cancer typically focuses on better recognition of cancer cells by the body's own immune system. Researchers at ...

Orca-T with reduced-intensity stem cell transplantation was a safe, feasible alternative to conventional transplant in blood ...

A retrospective analysis showed improved overall survival (OS) with Orca-T compared with post-transplant cyclophosphamide in ...

PRGN-2012—which Precigen has begun to call by its generic name of zopapogene imadenovec—is a gene therapy designed to elicit immune responses directed against cells infected with human papillomavirus ...

adolescents and young adults with acute lymphoblastic leukemia or non-Hodgkin's lymphoma MedImmune LLC NCT01508312 Brentuximab vedotin (SGN-35) in transplant eligible patients with relapsed or ...

Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.